Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05231 (
interleukin-6
)
23,907
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cancer remains the second most common cause of death in our society, and advanced disease is often refractory to surgical, chemotherapeutic, and radiologic interventions. One novel approach to cancer treatment involves targeting a cytotoxic agent to a cancer cell. Immunotoxins have been developed that contain a potent toxin (either Pseudomonas exotoxin,
ricin
toxin, or diphtheria toxin) coupled to a targeting moiety that directs the molecule to cells expressing a certain antigen. Chemically coupled immunotoxins have been developed over the past 12 years. These bind to and kill cells expressing many tumor-associated antigens. Initial clinical results were disappointing, but recent results have been more promising. Furthermore, newer immunotoxins have been developed that will soon be in clinical trials. Some of these are recombinant toxins that have been developed using techniques of genetic engineering. Transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-1, interleukin-2, interleukin-4,
interleukin-6
, the binding portions of monoclonal antibodies, and CD4 have been used to direct toxins to cancer cells or cells infected with the human immunodeficiency virus type 1. Efforts are under way to circumvent problems such as immunogenicity that may limit the clinical usefulness of immunotoxins.
...
PMID:Immunotoxins and recombinant toxins in the treatment of solid carcinomas. 836 39
The trichothecene mycotoxin deoxynivalenol (DON) induces systemic expression of the
interleukin-6
(
IL-6
) and other proinflammatory cytokines in the mouse. The purpose of this study was to test the hypothesis that DON triggers an endoplasmic reticulum (ER) stress response in murine macrophages capable of driving
IL-6
gene expression. DON at concentrations up 5000 ng/ml. was not cytotoxic to peritoneal cells. However, DON markedly decreased protein levels but not the mRNA levels of glucose-regulated protein (GRP) 78 (BiP), a chaperone known to mediate ER stress. Inhibitor studies suggested that DON-induced GRP78 degradation was cathepsin and calpain dependent but was proteosome-independent. RNAi-mediated knockdown of GRP78 resulted in increased
IL-6
gene expression indicating a potential downregulatory role for this chaperone. GRP78 is critical to the regulation of the two transcription factors, X-box binding protein 1 (XBP1) and activating transcription factor 6 (ATF6), which bind to cAMP-response element (CRE) and drive expression of CRE-dependent genes such as
IL-6
. DON exposure was found to increase IRE1alpha protein, its modified products spliced XBP1 mRNA and XBP1 protein as well as ATF6. Knockdown of ATF6 but not XBP1 partially inhibited DON-induced
IL-6
expression in the macrophages. Three other trichothecenes (satratoxin G, roridin, T-2 toxin) and the ribosome inhibitory protein
ricin
were also found to induce GRP78 degradation suggesting that other translation inhibitors might evoke ER stress. Taken together, these data suggest that in the macrophage DON induces GRP78 degradation and evokes an ER stress response that could contribute, in part, to DON-induced
IL-6
gene expression.
...
PMID:Role of GRP78/BiP degradation and ER stress in deoxynivalenol-induced interleukin-6 upregulation in the macrophage. 1933 99
Inhalation of
ricin
toxin is associated with the onset of acute respiratory distress syndrome (ARDS), characterized by hemorrhage, inflammatory exudates, and tissue edema, as well as the nearly complete destruction of the lung epithelium. Here we report that the Calu-3 human airway epithelial cell line is relatively impervious to the effects of
ricin
, with little evidence of cell death even upon exposure to microgram amounts of toxin. However, the addition of exogenous soluble
t
umor
n
ecrosis
f
actor (TNF)-
r
elated
a
poptosis-
i
nducing
l
igand (TRAIL; CD253) dramatically sensitized Calu-3 cells to
ricin
-induced apoptosis. Calu-3 cell killing in response to
ricin
and TRAIL exposure was partially inhibited by caspase-8 and caspase-3/7 inhibitors, consistent with involvement of extrinsic apoptotic pathways in cell death. We employed nCounter Technology to define the transcriptional response of Calu-3 cells to
ricin
, TRAIL, and the combination of
ricin
plus TRAIL. An array of genes associated with inflammation and cell death were significantly upregulated upon treatment with
ricin
toxin and were further amplified upon addition of TRAIL. Of particular note was
interleukin-6
(
IL-6
), whose expression in Calu-3 cells increased 300-fold upon
ricin
treatment and more than 750-fold upon
ricin
and TRAIL treatment.
IL-6
secretion by Calu-3 cells was confirmed by cytometric bead array analysis. On the basis of these finding, we speculate that the severe airway epithelial cell damage observed in animal models following
ricin
exposure is a result of a positive-feedback loop driven by proinflammatory cytokines such as TRAIL and
IL-6
.
IMPORTANCE
Ricin toxin is a biothreat agent that is particularly damaging to lung tissue following inhalation. A hallmark of
ricin
exposure is widespread inflammation and concomitant destruction of the airway epithelium. In this study, we investigated the possible interaction between
ricin
and known proinflammatory cytokines associated with lung tissue. Using an established human airway epithelial cell line, we demonstrate that epithelial cell killing by
ricin
is significantly enhanced in the presence of the proinflammatory cytokine known as TRAIL (CD253). Moreover, epithelial cells that are simultaneously exposed to
ricin
and TRAIL produced large amounts of secondary proinflammatory signals, including
IL-6
, which in the context of the lung would be expected to exacerbate toxin-induced tissue damage. Our results suggest that therapies designed to neutralize proinflammatory cytokines such as TRAIL and
IL-6
may limit the bystander damage associated with
ricin
exposure.
...
PMID:TRAIL (CD253) Sensitizes Human Airway Epithelial Cells to Toxin-Induced Cell Death. 3025 37